ArticleBMC surgery2026
Study on the migration of bacteria in transoral endoscopic thyroidectomy vestibular approach and development of a comprehensive oral management process.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe transoral endoscopic thyroidectomy vestibular approach (TOETVA) utilizes an intraoral incision, raising concerns about surgical-site infections (SSI) originating from the oral cavity. The types and sources of bacteria that may cause TOETVA infection are not clear, and the optimal antibiotic prevention plan is still unclear, lacking targeted perioperative management. MATERIALS AND
methodsIn this prospective, non-randomized controlled experimental study, drainage-fluid from 52 TOETVA and 15 open surgery patients (March - December 2025) was analyzed using 16S rDNA sequencing and clinical review. TOETVA patients were allocated to three perioperative antibiotic regimens: preoperative cefuroxime (Group A, n = 18), postoperative cefuroxime (Group B, n = 16), or postoperative metronidazole (Group C, n = 18). Inclusion criteria were initial surgery for T1N0M0 papillary thyroid carcinoma, no prior neck radiation, and patient preference for a scar-free neck. The primary outcome was postoperative SSI rate. Secondary outcomes included changes in drainage-fluid bacterial abundance, pus culture results, effects of different oral cleaning protocols, and microbial correlation between drainage-fluid and disinfected neck skin or oral vestibule. Statistical analyses employed the Chi-Square test, Kruskal-Wallis test, and Spearman Correlation.
resultsNo SSI occurred in cefuroxime group, while two infections were recorded in the metronidazole group. Analysis of the top 30 differentially abundant bacterial species showed that cefuroxime reduced the abundance of 15/30 (50%) within 48 h, compared to only 4/30 (13.3%) with metronidazole (OR: 6.50, 95% CI: 1.90-22.26, P = 0.0023). Microbial composition in drainage-fluid strongly correlated with povidone-iodine-disinfected chin skin (ρ = 0.8195, 95% CI: 0.6865-0.8994, P < 0.001). However, pus cultures from infected cases grew oral streptococci, not skin flora. Among four oral cleaning regimens, povidone-iodine most effectively reduced streptococcal load, whereas tinidazole better preserved the overall microbiota balance.
conclusionsAlthough the drainage-fluid following TOETVA primarily reflects skin microbiota, clinical surgical-site infections are mainly attributed to oral streptococci. Cefuroxime provides superior perioperative antibacterial coverage compared to metronidazole. Based on clinical practice considerations, a comprehensive oral management process can be helpful for the treatment of TOETVA.
trial registrationRetrospectively registered in Chinese Clinical Trial Registry on April 8, 2026 (Registration number: ChiCTR2600122005).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.